We determined the YO-2 toxicity profile using a dosage of 5 mg/kg body weight that reduced melanoma growth and induced p53 in murine models and a dosage of 10 mg/kg body weight of YO-2 in vivo. The gene discussed is TP53; the disease is melanoma.